INTERNAL MEDICINE JOURNAL, published by Wiley, stands as a prominent platform in the field of internal medicine, reflecting the latest advancements and research across a broad spectrum of topics within the discipline. With an ISSN of 1444-0903 and an E-ISSN of 1445-5994, this journal caters to a global audience, primarily situated in the United Kingdom. As a testament to its scholarly impact, the journal holds a Q2 ranking in the Internal Medicine category for 2023, indicating its influence within the field, and ranks #82 out of 167 in Scopus, placing it within the 51st percentile. Covering a convergence of years from 2001 to 2024, the INTERNAL MEDICINE JOURNAL aims to disseminate high-quality research that advances clinical practice, with diverse open access options available for broader readership and engagement. This publication is essential for researchers, healthcare professionals, and students seeking to deepen their understanding of internal medicine and contribute to its ongoing evolution.

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

The Annual Review of Medicine is a prestigious academic journal published by Annual Reviews that serves as a key resource for researchers, healthcare professionals, and students engaged in the fields of medicine and biochemistry. With its ISSN 0066-4219 and E-ISSN 1545-326X, this journal has been providing comprehensive reviews that cover major developments and trends in medical research since its inception in 1950. Impactful in its category, the Annual Review of Medicine ranks in the Q1 quartile for both Medicine (miscellaneous) and Biochemistry, Genetics and Molecular Biology (miscellaneous), establishing itself within the top percentiles of academic rigor and relevance, exemplified by its impressive Scopus rankings: Rank #12/636 and Rank #6/221 respectively. Although the journal is not open access, it remains an essential resource for contributing valuable insights into evolving medical disciplines, driving evidence-based practice, and fostering innovation among healthcare researchers. The Annual Review of Medicine is instrumental in shaping the future of medicine by synthesizing the most critical findings and fostering an informed understanding of diverse medical challenges.

Nephrologie & Therapeutique is a distinguished peer-reviewed journal published by JOHN LIBBEY EUROTEXT LTD, dedicated to the field of nephrology. Since its inception in 2005, this journal has been pivotal in disseminating high-quality research in the areas of kidney disease, renal therapies, and nephrological advancements, and it continues to serve as an essential resource for professionals, researchers, and students alike. With an ISSN of 1769-7255 and an E-ISSN of 1872-9177, the journal is indexed in Scopus and is currently ranked in the third quartile (Q3) within the nephrology category, showing significant contributions to the discipline, despite its current ranking of 64 out of 81. Although Nephrologie & Therapeutique does not operate under an open access model, it nevertheless provides valuable insights and updates on the latest findings and practices in nephrology, making it an important platform for academic discourse in this field. The journal's commitment to advancing knowledge and fostering interdisciplinary dialogue underscores its role as a key player in shaping future research and clinical practices in nephrology.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

CLINICAL MEDICINE is a distinguished academic journal dedicated to advancing the field of medicine, published by the Royal College of Physicians of London. Operating since 1973, it has established itself as a critical platform for disseminating innovative research and insights in the realm of clinical practice. With an impressive impact factor positioning it in the Q2 category within the broad spectrum of Medicine (miscellaneous) and ranking 56th out of 636 in General Medicine according to Scopus, the journal is a vital resource for researchers, practitioners, and students alike. CLINICAL MEDICINE provides open access options, ensuring that its findings are widely accessible to the global medical community, fostering collaboration and knowledge sharing. As the field of medicine continues to evolve, this journal remains committed to enhancing clinical practices through rigorous research, critical reviews, and comprehensive articles that examine contemporary challenges and breakthroughs in medicine.

TERAPEVTICHESKII ARKHIV, published by CJSC CONSILIUM MEDICUM, is a distinguished open-access journal that has been pivotal in the fields of Endocrinology, Family Practice, History, and Internal Medicine since its inception in 1949. Recognized in 2023 with quartile rankings of Q3 in Family Practice and notable placements in other categories, the journal aims to disseminate high-quality research, innovative treatment methods, and comprehensive reviews that advance the understanding of medical practices and historical contexts within these disciplines. With its commitment to accessibility, as demonstrated by its open-access policy initiated in 2018, TERAPEVTICHESKII ARKHIV serves as an invaluable resource for researchers, healthcare professionals, and students looking to stay abreast of cutting-edge advances and historical perspectives in medicine, especially within the Russian Federation. The journal’s focus on interdisciplinary approaches encourages a rich dialogue across various medical fields, underlining its significance in fostering a well-rounded academic community.

REVISTA CLINICA ESPANOLA, a leading journal in the field of general medicine, has been a pivotal platform for disseminating clinical research and advancements since its inception in 1947. Published by EDICIONES DOYMA S A in Barcelona, Spain, this journal plays a significant role in enhancing medical practice and research, as evidenced by its impressive Scopus ranking of #116 out of 636 in the field, placing it in the 81st percentile. Although it currently does not offer open access options, the journal continues to attract high-quality submissions focused on diverse medical topics, making it an essential resource for health professionals, researchers, and students alike. With a current categorization of Q3 in Medicine (miscellaneous), REVISTA CLINICA ESPANOLA remains committed to bridging the gap between clinical practice and research, thereby contributing to the overall improvement of healthcare outcomes.

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, published by SAGE PUBLICATIONS INC, stands as a vital resource in the fields of Endocrinology and Internal Medicine. With an impressive open access model established in 2014, this journal facilitates broad dissemination of high-quality research that explores the complex mechanisms and clinical implications of the renin-angiotensin-aldosterone system (RAAS). Currently, it is recognized within the 2023 Category Quartiles as Q3 in Endocrinology and Q2 in Internal Medicine, reflecting its significant impact on the scientific community. The journal ranks in the 75th percentile for Internal Medicine and the 57th percentile in Endocrinology according to Scopus, indicating its strong contributions to these disciplines. Covering a rich history from its inception in 2000 to the present, the journal aims to bridge the gap between basic research and clinical practice, thereby enhancing the understanding and treatment of conditions influenced by RAAS. The continuous publication of innovative research makes it an essential reference for researchers, healthcare professionals, and students engaged in these dynamic fields.